Kymera Therapeutics (KYMR) Assets (2019 - 2026)
Kymera Therapeutics (KYMR) reported Assets of $1.65 billion for Q2 2026, up 45.5% from $1.13 billion a year earlier but down 1.4% from the prior quarter.
Powered by 
Analysis
Kymera Therapeutics (KYMR) Assets (2019 - 2026) Analysis & Trends
At the end of FY2025, Kymera Therapeutics posted Assets of $1.74 billion, up 78.2% from FY2024.
- Assets has a five-year compound annual growth rate of 29.0% (FY2020 to FY2025).
- By year, Assets came in at $978.04 million in FY2024 (+69.9%), $575.76 million in FY2023 (-4.5%), $603.13 million in FY2022 (-0.5%) and $605.91 million in FY2021 (+24.4%).
- Five-year quarterly Assets spans a low of $523.42 million in Q2 2022 and a high of $1.74 billion in Q4 2025.
- Year over year, Assets has now increased in each of the last ten quarters, with growth averaging 51.5% over the last eight quarters.
- The high point for year-over-year Assets in five years was Q3 2024 (growth of 87.3%); the low point was Q3 2023 (a decline of 13.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.67 billion (Q1 2026), $1.74 billion (Q4 2025) and $1.1 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Kymera Therapeutics | 9.27 Bn | 6.58 Bn | - | 1.65 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.65 Bn |
| Mar 31, 2026 | 1.67 Bn |
| Dec 31, 2025 | 1.74 Bn |
| Sep 30, 2025 | 1.10 Bn |
| Jun 30, 2025 | 1.13 Bn |
| Mar 31, 2025 | 918.31 Mn |
| Dec 31, 2024 | 978.04 Mn |
| Sep 30, 2024 | 1.03 Bn |
| Jun 30, 2024 | 826.02 Mn |
| Mar 31, 2024 | 868.25 Mn |
| Dec 31, 2023 | 575.76 Mn |
| Sep 30, 2023 | 552.38 Mn |
| Jun 30, 2023 | 581.95 Mn |
| Mar 31, 2023 | 613.91 Mn |
| Dec 31, 2022 | 603.13 Mn |
| Sep 30, 2022 | 638.47 Mn |
| Jun 30, 2022 | 523.42 Mn |
| Mar 31, 2022 | 563.06 Mn |
| Dec 31, 2021 | 605.91 Mn |
| Sep 30, 2021 | 642.45 Mn |
API Access
Kymera Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=KYMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "KYMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=KYMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();